Research ExplorerJournalsVACCINE Publications

VACCINE

1 - 22 out of 22Page size: 50

Publications

  1. 2022

  2. Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany

    Sprengholz, P., Korn, L., Eitze, S., Felgendreff, L., Siegers, R., Goldhahn, L., De Bock, F., Huebl, L., Böhm, R. & Betsch, C., 05.12.2022, In: VACCINE. 40, 51, p. 7370-7377 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls

    Mischlinger, J., Jaeger, V. K., Ciurea, A., Gabay, C., Hasler, P., Mueller, R. B., Siegrist, C. A., Villiger, P., Walker, U. A., Hatz, C. & Bühler, S., 05.08.2022, In: VACCINE. 40, 33, p. 4897-4904 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies

    Albrecht, M., Pagenkemper, M., Wiessner, C., Spohn, M., Lütgehetmann, M., Jacobsen, H., Gabriel, G., Zazara-Giannou, D. E., Haertel, C., Hecher, K., Diemert, A. & Arck, P. C., 08.03.2022, In: VACCINE. 40, 11, p. 1563-1571 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study

    Herzberg, J., Vollmer, T., Fischer, B., Becher, H., Becker, A-K., Honarpisheh, H., Guraya, S. Y., Strate, T. & Knabbe, C., 21.01.2022, In: VACCINE. 40, 2, p. 206-212 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2021

  7. Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA)

    Prelog, M., Almanzar, G., Stern, R., Robrade, K., Holzer, M. T., Winzig, C., Kleines, M., Stiasny, K., Meyer, T., Speth, F. & Haas, J. P., 24.09.2021, In: VACCINE. 39, 40, p. 5918-5927 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study

    Joura, E. A., Ulied, A., Vandermeulen, C., Rua Figueroa, M., Seppä, I., Hernandez Aguado, J. J., Ahonen, A., Reich, O., Virta, M., Perino, A., Peris Tuser, M., Peters, K., Origoni, M., Raspagliesi, F., Tjalma, W. A. A., Tummers, P., Woelber, L., Nieminen, P., van Damme, P., Sehouli, J., Fiol Ruiz, G., Brucker, S., Fehm, T., Cheon, K., Rawat, S., Luxembourg, A. & Wittke, F., 12.05.2021, In: VACCINE. 39, 20, p. 2800-2809 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2020

  10. Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals

    Burkhard, J., Ciurea, A., Gabay, C., Hasler, P., Müller, R., Niedrig, M., Fehr, J., Villiger, P., Visser, L. G., de Visser, A. W., Walker, U. A., Hatz, C. & Bühler, S., 23.04.2020, In: VACCINE. 38, 19, p. 3610-3617 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2018

  12. Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV

    Fischer, T., Spohn, M., Olearo, F., Zinser, M. E., Kasonta, R., Stubbe, H. C., Rechtien, A., Ly, M. L., Schmiedel, S., Lohse, A. W., Grundhoff, A., Addo, M. M., Dahlke, C. & VEBCON, 12.11.2018, In: VACCINE. 36, 46, p. 7083-7094 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab

    Reher, D., Fuhrmann, V., Kluge, S. & Nierhaus, A., 03.05.2018, In: VACCINE. 36, 19, p. 2507-2509 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial

    Schoeps, A., Nebié, E., Fisker, A. B., Sié, A., Zakane, A., Müller, O., Aaby, P. & Becher, H., 05.04.2018, In: VACCINE. 36, 15, p. 1965-1971 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2017

  16. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso

    Pfeiffer, G., Fisker, A. B., Nebié, E., Hengelbrock, J., Sié, A., Becher, H. & Müller, O., 18.12.2017, In: VACCINE. 35, 51, p. 7114-7120 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Antibody persistence and evidence of immune memory at 5 years following administration of the 9-valent HPV vaccine

    Guevara, A., Cabello, R., Woelber, L., Moreira, E. D., Joura, E., Reich, O., Shields, C., Ellison, M. C., Joshi, A. & Luxembourg, A., 05.09.2017, In: VACCINE. 35, 37, p. 5050-5057 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2015

  19. The ESPID/ESWI Joint Symposium - A strong vote for universal influenza vaccination in children in Europe

    Kobbe, R., 08.12.2015, In: VACCINE. 33, 49, p. 6967-9 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers

    Roggelin, L., Vinnemeier, C. D., Fischer-Herr, J., Johnson-Weaver, B. T., Rolling, T., Burchard, G. D., Staats, H. F. & Cramer, J. P., 07.08.2015, In: VACCINE. 33, 33, p. 4141-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Re: Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City

    Rau, C. J. & Danovaro-Holliday, M. C., 26.06.2015, In: VACCINE. 33, 29, p. 3273

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2014

  23. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study

    Harrer, T., Plettenberg, A., Arastéh, K., Van Lunzen, J., Fätkenheuer, G., Jaeger, H., Janssens, M., Burny, W., Collard, A., Roman, F., Loeliger, A., Koutsoukos, M., Bourguignon, P., Lavreys, L. & Voss, G., 07.05.2014, In: VACCINE. 32, 22, p. 2657-2665 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2013

  25. Socio-demographic determinants of timely adherence to BCG, Penta3, measles, and complete vaccination schedule in Burkina Faso

    Schoeps, A., Ouédraogo, N., Kagoné, M., Sié, A., Müller, O. & Becher, H., 17.12.2013, In: VACCINE. 32, 1, p. 96-102 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2012

  27. Passive immunization with a monoclonal IgM antibody specific for Strongyloides ratti HSP60 protects mice against challenge infection.

    Nadia, B. N., Piedavent, M., Osterloh, A. & Breloer, M., 2012, In: VACCINE. 30, 33, p. 4971-4976 33.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response.

    Nouir, N. B., Eschbach, M-L., Piedavent, M., Osterloh, A., Kingsley, M. T., Erttmann, K., Brattig, N., Liebau, E., Fleischer, B. & Breloer, M., 2012, In: VACCINE. 30, 5, p. 862-871 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 2010

  30. Immunizing school-age children and adolescents: experience from low- and middle-income countries

    Mackroth, M. S., Irwin, K., Vandelaer, J., Hombach, J. & Eckert, L. O., 03.02.2010, In: VACCINE. 28, 5, p. 1138-47 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  31. 2008

  32. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.

    Tartz, S., Rüssmann, H., Kamanova, J., Sebo, P., Sturm, A., Heussler, V., Fleischer, B. & Jacobs, T., 2008, In: VACCINE. 26, 47, p. 5935-5943 47.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 2007

  34. Understanding the natural variability of prion diseases.

    Geissen, M., Krasemann, S., Matschke, J. & Glatzel, M., 2007, In: VACCINE. 25, 30, p. 5631-5636 30.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research